| International Consensus Guidelines for the Optimal Use of the Polymyxins Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP) |
86 |
| Trends and Variation in Oral Anticoagulant Choice in Patients with Atrial Fibrillation, 2010-2017 |
34 |
| Review and Validation of Bayesian Dose-Optimizing Software and Equations for Calculation of the Vancomycin Area Under the Curve in Critically Ill Patients |
21 |
| Duration of Exposure to Antipseudomonal beta-Lactam Antibiotics in the Critically Ill and Development of New Resistance |
21 |
| Augmented Renal Clearance |
18 |
| Lefamulin: Review of a Promising Novel Pleuromutilin Antibiotic |
17 |
| Plazomicin: A Next-Generation Aminoglycoside |
16 |
| Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center |
16 |
| Shortened Courses of Antibiotics for Bacterial Infections: A Systematic Review of Randomized Controlled Trials |
15 |
| Effects of Atypical Antipsychotic Treatment and Resistant Starch Supplementation on Gut Microbiome Composition in a Cohort of Patients with Bipolar Disorder or Schizophrenia |
14 |
| Association between Development of Dementia and Use of Benzodiazepines: A Systematic Review and Meta-Analysis |
13 |
| Meropenem and Vaborbactam: Stepping up the Battle against Carbapenem-resistant Enterobacteriaceae |
13 |
| Implementation Science to Advance Care Delivery: A Primer for Pharmacists and Other Health Professionals |
13 |
| Reappraisal of Contemporary Pharmacokinetic and Pharmacodynamic Principles for Informing Aminoglycoside Dosing |
12 |
| Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol |
11 |
| Compassionate Use of Cefiderocol in the Treatment of an Intraabdominal Infection Due to Multidrug-Resistant Pseudomonas aeruginosa: A Case Report |
11 |
| Pharmacokinetics and Pharmacodynamics of beta-Lactamase Inhibitors |
11 |
| Anticholinergics Influence Transition from Normal Cognition to Mild Cognitive Impairment in Older Adults in Primary Care |
11 |
| Effectiveness of Melatonin for the Prevention of Intensive Care Unit Delirium |
10 |
| Predictive Analytics for Identification of Patients at Risk for QT Interval Prolongation: A Systematic Review |
10 |
| Current and Emerging Pharmacotherapies for Cessation of Tobacco Smoking |
10 |
| Cannabis for Chronic Pain: Challenges and Considerations |
10 |
| Risks of Major Long-Term Side Effects Associated with Androgen-Deprivation Therapy in Men with Prostate Cancer |
10 |
| Polymyxin B Pharmacokinetics in Adult Cystic Fibrosis Patients |
10 |
| Integrase Inhibitors: After 10 Years of Experience, Is the Best Yet to Come? |
10 |
| The Safety and Efficacy of Low-Dose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohn's Disease, and Other Chronic Pain Disorders |
10 |
| Guideline-Directed Medical Therapy and Survival Following Hospitalization in Patients with Heart Failure |
9 |
| Innovative Use of Novel Biomarkers to Improve the Safety of Renally Eliminated and Nephrotoxic Medications |
9 |
| Implementation of a Stewardship Initiative on Respiratory Viral PCR-based Antibiotic Deescalation |
9 |
| Ketamine for the Acute Management of Excited Delirium and Agitation in the Prehospital Setting |
9 |
| Catecholamine Vasopressor Support Sparing Strategies in Vasodilatory Shock |
9 |
| Procalcitonin Monitoring as a Guide for Antimicrobial Therapy: A Review of Current Literature |
8 |
| Ketamine Infusion for Adjunct Sedation in Mechanically Ventilated Adults |
8 |
| Influence of Age on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage |
8 |
| Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study |
8 |
| Suboptimal Clinical Response Rates with Newer Antibiotics Among Patients with Moderate Renal Impairment: Review of the Literature and Potential Pharmacokinetic and Pharmacodynamic Considerations for Observed Findings |
8 |
| Intravenous Lidocaine for Acute Pain: A Systematic Review |
8 |
| What Is Old Is New Again: Delafloxacin, a Modern Fluoroquinolone |
8 |
| Prospective Open-label Trial of Early Concomitant Vasopressin and Norepinephrine Therapy versus Initial Norepinephrine Monotherapy in Septic Shock |
8 |
| Hypotension Risk Based on Vasoactive Agent Discontinuation Order in Patients in the Recovery Phase of Septic Shock |
7 |
| Quality of Prescribing by Physicians, Nurse Practitioners, and Physician Assistants in the United States |
7 |
| Predictors of Gabapentin Overuse With or Without Concomitant Opioids in a Commercially Insured US Population |
7 |
| Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database |
7 |
| Synthetic Cannabinoid-Associated Multiple Organ Failure: Case Series and Literature Review |
7 |
| Pharmacokinetics of the Meropenem Component of Meropenem-Vaborbactam in the Treatment of KPC-Producing Klebsiella pneumoniae Bloodstream Infection in a Pediatric Patient |
7 |
| Incidence of Acute Kidney Injury Among Patients Receiving the Combination of Vancomycin with Piperacillin-Tazobactam or Meropenem |
7 |
| Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care Databases |
7 |
| Long-Term Beta-Blocker Therapy after Myocardial Infarction in the Reperfusion Era: A Systematic Review |
7 |
| Association Between Medication Adherence and the Outcomes of Heart Failure |
7 |
| Efficacy and Safety of Rituximab for the Treatment of Graves' Orbitopathy: A Meta-analysis of Randomized Controlled Trials |
7 |
